Evidence map›Paper›PMID 40826389›Full record

Observational studyBMC gastroenterology2025

Gluten-free diet adherence patterns and health outcomes in celiac disease: a retrospective observational study.

Saba Rahimi, Mohadeseh Mahmoudi Ghehsareh, Nastaran Asri, Mehdi Azizmohammad Looha, Somayeh Jahani-Sherafat, Carolina Ciacci, Mohammad Rostami-Nejad

Abstract readObservational Study
In one paragraph

Observational study in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saba RahimiCeliac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohadeseh Mahmoudi GhehsarehCeliac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nastaran AsriGastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mehdi Azizmohammad LoohaBasic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Somayeh Jahani-SherafatLaser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Carolina CiacciDepartment of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Mohammad Rostami-NejadCeliac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. m.rostamii@gmail.com.ORCID http://orcid.org/0000-0003-2495-1831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCeliac disease (CeD) is an autoimmune disorder, causing significant gastrointestinal (GI) and non-GI symptoms. The only effective treatment is a gluten-free diet (GFD), but adherence can be challenging. This study investigates GFD adherence among CeD patients and the change in their clinical and pathological conditions over time.

methodsA telephone-based retrospective observational analysis conducted between November 2022 and June 2023 enrolled 300 participants with confirmed CeD, selected via systematic sampling from an initial cohort of 1,268 individuals. A comprehensive questionnaire assessed demographics, clinical symptoms, and GFD adherence. Participants were categorized into short/meidum-term (≤ 6 months), long-term (6-24 months), and very long-term (≥ 24 months) GFD adherence groups. All statistical analyses were conducted using R (version 4.3.1), employing a variety of packages tailored for descriptive and inferential statistics.

resultsParticipants' mean age was 41.58 (± 12.37) years, with females constituting 73.67% (n = 221/300). GFD adherence was assessed, revealing that 55.33% (n = 166/300) of patients adhered strictly to the diet, while 28.33% (n = 85/300) experienced worsening adherence over time (p = 0.001). Significant improvements were observed in GI and non-GI symptoms across disease duration, with abdominal pain absence increasing from 71.2 to 84.9% (p < 0.01), and depression absence improving from 63.6 to 89.6% (p < 0.001). Additionally, laboratory values such as VitD and HCT showed improvement (p < 0.05), while the comorbidity burden decreased significantly (p = 0.001).

conclusionsEnhanced patient support, including dietary and mental health resources, is vital for improving outcomes in CeD patients. Further research should explore barriers to adherence and the psychosocial effects of living with CeD.

Indexed as

Celiac DiseaseDiet, Gluten-FreePatient ComplianceAdultFemaleHumansMaleMiddle AgedRetrospective StudiesSurveys and QuestionnairesCeliac diseaseFollow-upGastrointestinal symptomsGluten-free dietNon-gastrointestinal symptoms

Identifiers

PMID40826389
PMCPMC12359905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.